Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07416435
Eligibility Criteria:
Inclusion Criteria:
* • women aged \>18 years
* patients with primary ovarian cancer eligible for CRS
* primary ovarian cancer patients with no extraperitoneal metastatic disease
Exclusion Criteria:
* • patients with significant comorbidities (hepatic or renal failure, severe cardiovascular or pulmonary patients with hepatic metastases
* newly diagnosed pulmonary embolism.
* criteria set by Aletti and colleagues (age \>75 years, serum albumin 3.0 g/dL, and American Society of Anesthesiologists classification score ≥3 or extensive disease).
* Unresectable stage IVB disease found on preoperative imaging which defined as multiple parenchymal liver metastases, pulmonary metastases including diffuse pleural involvement, brain metastases, or bulky thoracic adenopathy (not including anterior, lateral, or posterior cardiophrenic lymphade nopathy).
* Patients who received initial treatment elsewhere or is known non-epithelial ovarian carcinoma histology on pathology
* patients refused to participate in study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07416435
Study Brief:
Protocol Section:
NCT07416435